USE OF PARTIAL CARDIOPULMONARY BYPASS DURING THE ANHEPATIC PHASE OF ORTHOTOPIC LIVER GRAFTING

被引：48
|
作者：
CALNE, RY
SMITH, DP
MCMASTER, P
CRADDOCK, GN
ROLLES, K
FARMAN, JV
LINDOP, M
BETHUNE, DW
WHEELDON, D
GILL, R
WILLIAMS, R
机构：
[1] ADDENBROOKES HOSP,DEPT ANAESTHET,CAMBRIDGE CB2 2QQ,ENGLAND
[2] UNIV LONDON KINGS COLL HOSP,LIVER UNIT,LONDON SE5 8RX,ENGLAND
[3] PAPWORTH HOSP,CAMBRIDGE,ENGLAND
来源：
LANCET | 1979年 / 2卷 / 8143期
关键词：
D O I：
10.1016/S0140-6736(79)91668-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Femoro-femoral partial cardiopulmon- ary bypass has been used in two patients undergoing orthotopic liver allografting who has severe cardiovascular disturbances on trial clamping of their venæ cavæ. Flows of 2-3 litres/min resulted in satisfactory cardiovascular control during the anhepatic phase in each case. A third patient who tolerated caval clamping withstood the grafting without bipass. Having bypass available for use in critical cases could increase the safety of orthotopic liver transplantation. © 1979.
引用
收藏
页码：612 / 614
页数：3
相关论文
共 50 条
  • [31] Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation
    Joseph, SE
    Heaton, N
    Potter, D
    Pernet, A
    Umpleby, MA
    Amiel, SA
    DIABETES, 2000, 49 (03) : 450 - 456
  • [32] Pulmonary effects of anhepatic phase of liver transplantation without venovenous bypass in acute or chronic liver failure
    Valta, P
    Pere, P
    Mäkisalo, H
    Lindgren, L
    ANESTHESIOLOGY, 1999, 91 (3A) : U481 - U481
  • [33] Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting
    Mirow, N
    Minami, K
    KLeikamp, G
    Tenderich, G
    Puhlmann, T
    Körfer, R
    THORACIC AND CARDIOVASCULAR SURGEON, 2001, 49 (03) : 131 - 136
  • [34] Sequential coronary artery bypass grafting and orthotopic liver transplantation: A case report
    Manas, DM
    Roberts, DRD
    Heaviside, DW
    Chaudhry, S
    Tocewicz, K
    Hudson, M
    Bayly, P
    Thick, M
    Dark, J
    James, OFW
    CLINICAL TRANSPLANTATION, 1996, 10 (03) : 320 - 322
  • [35] Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting
    Axelrod, D
    Koffron, A
    DeWolf, A
    Baker, A
    Fryer, J
    Baker, T
    Frederiksen, J
    Horvath, K
    Abecassis, M
    LIVER TRANSPLANTATION, 2004, 10 (11) : 1386 - 1390
  • [36] ADVANTAGES OF VENOUS BYPASS DURING ORTHOTOPIC TRANSPLANTATION OF THE LIVER
    SHAW, BW
    MARTIN, DJ
    MARQUEZ, JM
    KANG, YG
    BUGBEE, AC
    IWATSUKI, S
    GRIFFITH, BP
    HARDESTY, RL
    BAHNSON, HT
    STARZL, TE
    SEMINARS IN LIVER DISEASE, 1985, 5 (04) : 344 - 348
  • [37] Consecutive coronary artery bypass grafting and orthotopic living donor liver transplantation
    Sever, Kenan
    Kilercik, Hakan
    Akyildiz, Murat
    Dinckan, Ayhan
    Mansuroglu, Denyan
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 25 (04): : 647 - 649
  • [38] Severe Acute Hyperkalemia during Pre-Anhepatic Stage in Cadaveric Orthotopic Liver Transplantation
    Sahmeddini, Mohammad Ali
    Khosravi, Mohammad Bagher
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2012, 37 (03) : 208 - 210
  • [39] Combined coronary artery bypass grafting and orthotopic liver transplantation: A case report
    Kniepeiss, D
    Iberer, F
    Grasser, B
    Schaffellner, S
    Tscheliessnigg, KH
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 817 - 818
  • [40] Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass
    Massoudy, P
    Zahler, S
    Becker, BF
    Braun, SL
    Barankay, A
    Meisner, H
    CHEST, 2001, 119 (01) : 31 - 36
12345